206 related articles for article (PubMed ID: 10194143)
1. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
[TBL] [Abstract][Full Text] [Related]
3. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Duarte AG; Momii K; Bidani A
Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
[TBL] [Abstract][Full Text] [Related]
4. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
5. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume.
Mouloudi E; Katsanoulas K; Anastasaki M; Hoing S; Georgopoulos D
Intensive Care Med; 1999 Nov; 25(11):1215-21. PubMed ID: 10654204
[TBL] [Abstract][Full Text] [Related]
7. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
10. Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients.
Dhand R; Duarte AG; Jubran A; Jenne JW; Fink JB; Fahey PJ; Tobin MJ
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):388-93. PubMed ID: 8756811
[TBL] [Abstract][Full Text] [Related]
11. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P; Hederer B; Austen G; Dewberry H; Meyer T
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
[TBL] [Abstract][Full Text] [Related]
12. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution.
Marlin GE
Respiration; 1986; 50 Suppl 2():290-3. PubMed ID: 2951824
[TBL] [Abstract][Full Text] [Related]
13. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
[TBL] [Abstract][Full Text] [Related]
14. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
Goldberg J; Freund E; Beckers B; Hinzmann R
Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
Wesseling G; Mostert R; Wouters EF
Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
[TBL] [Abstract][Full Text] [Related]
16. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
Musil J; Hirsch V; Vondra V; Reisová M
Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
[TBL] [Abstract][Full Text] [Related]
17. Duration of salbutamol-induced bronchodilation delivered by metered-dose inhaler in mechanically ventilated COPD patients.
Mouloudi E; Maliotakis C; Kondili E; Kafetzakis A; Georgopoulos D
Monaldi Arch Chest Dis; 2001 Jun; 56(3):189-94. PubMed ID: 11665496
[TBL] [Abstract][Full Text] [Related]
18. Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPD.
Kilfeather SA; Ponitz HH; Beck E; Schmidt P; Lee A; Bowen I; Hesse Ch
Respir Med; 2004 May; 98(5):387-97. PubMed ID: 15139567
[TBL] [Abstract][Full Text] [Related]
19. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
20. [Basic medication of chronic obstructive lung disease with berodual].
Melent'eva EM
Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
